Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity
- 31 January 2010
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 64 (1), 73-76
- https://doi.org/10.1016/j.biopha.2009.09.009
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicityBiomedicine & Pharmacotherapy, 2009
- NOV-002, a mimetic of glutathione disulfideExpert Opinion on Investigational Drugs, 2008
- NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox BalanceCancer Research, 2008
- HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATINDrug Metabolism and Disposition, 2003
- Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule CellsJournal of the American Society of Nephrology, 2003
- Inhibition of γ-Glutamyl Transpeptidase or CysteineS-Conjugate β-Lyase Activity Blocks the Nephrotoxicity of Cisplatin in MiceThe Journal of pharmacology and experimental therapeutics, 2002
- Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.2000
- Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trialAnnals of Oncology, 1997
- Phase I Trial of Cisplatin in Combination with GlutathioneGynecologic Oncology, 1994
- Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatinBiochemical Pharmacology, 1984